Adverse ReNal OuTcomEs in patients with NoN-Valvular Atrial fibrillation treated with Rivaroxaban or Vitamin K Antagonists (ANTENNA)First published 05/03/2020 Last updated 29/03/2024 EU PAS number: EUPAS33537StudyFinalised